BIOT 104-Development and implementation of a manufacturing scale virus filtration step for monoclonal antibody production

被引:0
|
作者
Hsii, Judy F. [1 ]
Dowd, Chris [1 ]
机构
[1] Genentech Inc, Bioproc Dev Late Stage Purificat, San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
104-BIOT
引用
收藏
页数:1
相关论文
共 10 条
  • [1] BIOT 114-Development of a high throughput virus filtration step
    Liu, Hui F.
    Hove, Sarah
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [2] BIOT 154-Monoclonal antibody production in large-scale disposable bioreactors
    Giandomenico, Donna
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [3] BIOT 445-An economic analysis of the manufacturing costs associated with monoclonal antibody pilot plant production (2000-L scale)
    Ly, Nguyen V.
    Torres, Francis
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [4] BIOT 243-Qualification of a reduced scale perfusion bioreactor model for a monoclonal antibody production bioreactor process
    Villacorta, Reginald
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [5] BIOT 108-Development of an affinity chromatography elution step to enhance stability of a therapeutic monoclonal antibody: An aggregation case study
    Chmielowski, Rebecca
    Roush, David J.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [6] BIOT 99-Agitation and aeration of GS-NS0 cell culture for large-scale monoclonal antibody production
    Adams, Derek
    Heckathorn, Robert
    Frieden, Eric
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [7] PILOT SCALE PRODUCTION OF A HUMAN MONOCLONAL-ANTIBODY AGAINST HUMAN IMMUNODEFICIENCY VIRUS HIV-1
    JUNGBAUER, A
    TAUER, C
    WENISCH, E
    STEINDL, F
    PURTSCHER, M
    REITER, M
    UNTERLUGGAUER, F
    BUCHACHER, A
    UHL, K
    KATINGER, H
    [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1989, 19 (2-3): : 223 - 240
  • [8] Development and fine-tuning of a scale down model for process characterization studies of a monoclonal antibody upstream production process
    Mareike Harmsen
    Jimmy Stofferis
    Laetitia Malphettes
    [J]. BMC Proceedings, 5 (Suppl 8)
  • [9] Process development for the large scale production of clinical grade human monoclonal antibody using a Cytopilot fluidized bed reactor
    Klima, G
    Kreismayr, G
    Muller, D
    Schmatz, C
    Wiederkum, S
    Steinfellner, W
    Assadian, A
    Lhota, G
    Bluml, G
    DoblhoffDier, O
    Katinger, H
    [J]. ANIMAL CELL TECHNOLOGY: FROM VACCINES TO GENETIC MEDICINE, 1997, : 447 - 450
  • [10] BIOT 158-Development of a perfusion fibrous-bed bioreactor for continuous production of monoclonal antibody by CHO with on-line cell density monitoring and fast off-line mAb determination
    Bai, Yunling
    Zhang, Xudong
    Ouyang, Anli
    Yang, Shang-Tian
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232